The 2.8 A crystal structure of Gla-domainless activated protein C
- PMID: 9003757
- PMCID: PMC452507
The 2.8 A crystal structure of Gla-domainless activated protein C
Abstract
The structure of the Gla-domainless form of the human anticoagulant enzyme activated protein C has been solved at 2.8 A resolution. The light chain is composed of two domains: an epidermal growth factor (EGF)-like domain modified by a large insert containing an additional disulfide, followed by a typical EGF-like domain. The arrangement of the long axis of these domains describes an angle of approximately 80 degrees. Disulfide linked to the light chain is the catalytic domain, which is generally trypsin-like but contains a large insertion loop at the edge of the active site, a third helical segment, a prominent cationic patch analogous to the anion binding exosite I of thrombin and a trypsin-like Ca[II] binding site. The arrangement of loops around the active site partially restricts access to the cleft. The S2 and S4 subsites are much more polar than in factor Xa and thrombin, and the S2 site is unrestricted. While quite open and exposed, the active site contains a prominent groove, the surface of which is very polar with evidence for binding sites on the primed side, in addition to those typical of the trypsin class found on the non-primed side.
Similar articles
-
Structure of human des(1-45) factor Xa at 2.2 A resolution.J Mol Biol. 1993 Aug 5;232(3):947-66. doi: 10.1006/jmbi.1993.1441. J Mol Biol. 1993. PMID: 8355279
-
The 2.3 A crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator.J Mol Biol. 1996 Apr 26;258(1):117-35. doi: 10.1006/jmbi.1996.0238. J Mol Biol. 1996. PMID: 8613982
-
Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).J Struct Biol. 1999 Oct;127(3):213-23. doi: 10.1006/jsbi.1999.4158. J Struct Biol. 1999. PMID: 10544046
-
Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.J Mol Biol. 2007 Aug 17;371(3):774-86. doi: 10.1016/j.jmb.2007.05.042. Epub 2007 May 18. J Mol Biol. 2007. PMID: 17588602
-
Contributions of Gla and EGF-like domains to the function of vitamin K-dependent coagulation factors.Crit Rev Eukaryot Gene Expr. 1999;9(1):59-88. Crit Rev Eukaryot Gene Expr. 1999. PMID: 10200912 Review.
Cited by
-
Expression and functional characterisation of natural R147W and K150del variants of protein C in the Chinese population.Thromb Haemost. 2013 Apr;109(4):614-24. doi: 10.1160/TH12-10-0760. Epub 2013 Feb 7. Thromb Haemost. 2013. PMID: 23389250 Free PMC article.
-
Cytoprotective protein C pathways and implications for stroke and neurological disorders.Trends Neurosci. 2011 Apr;34(4):198-209. doi: 10.1016/j.tins.2011.01.005. Epub 2011 Feb 25. Trends Neurosci. 2011. PMID: 21353711 Free PMC article. Review.
-
Capturing spontaneous partitioning of peripheral proteins using a biphasic membrane-mimetic model.J Phys Chem B. 2011 Jun 2;115(21):7029-37. doi: 10.1021/jp109631y. Epub 2011 May 11. J Phys Chem B. 2011. PMID: 21561114 Free PMC article.
-
Protein C anticoagulant and cytoprotective pathways.Int J Hematol. 2012 Apr;95(4):333-45. doi: 10.1007/s12185-012-1059-0. Epub 2012 Apr 5. Int J Hematol. 2012. PMID: 22477541 Free PMC article. Review.
-
Ile73Asn mutation in protein C introduces a new N-linked glycosylation site on the first EGF-domain of protein C and causes thrombosis.Haematologica. 2020 Jun;105(6):1712-1722. doi: 10.3324/haematol.2019.227033. Epub 2019 Aug 8. Haematologica. 2020. PMID: 31399531 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases